FDA Gets Heat On Pharma Ad Risk Disclosures
The U.S. Food and Drug Administration is feeling pressure on multiple fronts as it considers relaxing risk disclosures in prescription drug commercials, according to comments released Wednesday from manufacturers trying to...To view the full article, register now.
Already a subscriber? Click here to view full article